Rallybio Corporation
0.93
0.04 (4.49%)
At close: Jan 15, 2025, 11:04 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 150.00K 167.00K 109.00K 62.03K 26.34K
Gross Profit -150.00K -167.00K -109.00K -62.03K -26.34K
Operating Income -78.93M -67.88M -45.65M -25.30M -17.64M
Interest Income 6.15M 1.96M 54.00K 171.00K 197.00K
Pretax Income -74.56M -65.58M -45.51M -24.94M -17.46M
Net Income -74.56M -66.49M -47.01M -24.93M -17.63M
Selling & General & Admin 25.39M 27.20M 18.74M 7.67M 6.28M
Research & Development 53.39M 40.69M 26.91M 17.63M 11.37M
Other Expenses n/a 342.00K 96.00K 241.00K 24.00K
Operating Expenses 78.93M 67.88M 45.65M 25.30M 17.64M
Interest Expense n/a n/a 10.00K 49.00K 39.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 78.93M 67.88M 45.65M 25.30M 17.64M
Income Tax -2.04M 908.00K 1.50M -15.00K 166.00K
Shares Outstanding (Basic) 40.45M 31.82M 32.13M 32.13M 32.13M
Shares Outstanding (Diluted) 40.45M 31.82M 32.13M 32.13M 32.13M
EPS (Basic) -1.84 -2.09 -1.46 -0.78 -0.55
EPS (Diluted) -1.84 -2.09 -1.46 -0.78 -0.55
EBITDA -72.37M -65.41M -45.39M -24.83M -17.39M
Depreciation & Amortization 150.00K 167.00K 109.00K 62.03K 26.34K